Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study.

Publikation

Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study.

Wissenschaftlicher Artikel/Review - 07.06.2021

Arnold Markus, Schweizer Juliane, Nakas Christos T, Schütz Valerie, Westphal Laura Philine, Inauen Corinne, Pokorny Thomas, Luft Andreas R, Leichtle Alexander, Arnold Marcel, Bicvic Antonela, Fischer Urs, De Marchis Gian Marco, Bonati Leo H, Delignette-Muller Marie Laure, Kahles Timo, Nedeltchev Krassen, Cereda Carlo W, Kägi Georg, Bustamante Alejandro, Montaner Joan, Ntaios Georges, Foerch Christian, Spanaus Katharina, von Eckardstein Arnold, Katan Mira

Zitation

Arnold M, Schweizer J, Nakas C, Schütz V, Westphal L, Inauen C, Pokorny T, Luft A, Leichtle A, Arnold M, Bicvic A, Fischer U, De Marchis G, Bonati L, Delignette-Muller M, Kahles T, Nedeltchev K, Cereda C, Kägi G, Bustamante A, Montaner J, Ntaios G, Foerch C, Spanaus K, von Eckardstein A, Katan M. Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study. Eur Heart J 2021; 42:2186-2196.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Eur Heart J 2021; 42

Veröffentlichungsdatum

07.06.2021

eISSN (Online)

1522-9645

Seiten

2186-2196

Kurzbeschreibung/Zielsetzung

Lipoprotein(a) [Lp(a)] is a recognized causal risk factor for atherosclerotic cardiovascular disease but its role for acute ischaemic stroke (AIS) is controversial. In this study, we evaluated the association of Lp(a) with large artery atherosclerosis (LAA) stroke and risk of recurrent cerebrovascular events in AIS patients.